Search research articles
Contact Us
Filters
Showing results (31-40 of 109) with videos related to
Page
of 11
Sort By:
Leukemia & Lymphoma
|
September 18, 2015
A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma
Stefano Luminari, Maria Goldaniga, Marina Cesaretti, et al.
Cancers
|
July 2, 2021
High Basal Maximal Standardized Uptake Value (SUV<sub>max</sub>) in Follicular Lymphoma Identifies Patients with a Low Risk of Long-Term Relapse
Giovanni Manfredi Assanto, Giulia Ciotti, Mattia Brescini, et al.
Leukemia & Lymphoma
|
October 29, 2009
Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma
Elena Cavalieri, Angela Matturro, Giorgia Annechini, et al.
European Journal of Haematology
|
December 21, 2025
Outpatient Versus Inpatient Azacitidine Plus Venetoclax Regimen in Elderly Acute Myeloid Leukemia: A Multicenter Retrospective Analysis
Deborah Kasmi, Maria Laura Bisegna, Ida Carmosino, et al.
Cancer Medicine
|
March 19, 2016
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years
Beatrice Casadei, Cinzia Pellegrini, Alessandro Pulsoni, et al.
Hematological Oncology
|
December 15, 2022
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study
Giovanni Manfredi Assanto, Alice Di Rocco, Francesco Malfona, et al.
British Journal of Haematology
|
May 1, 2021
The current role of interferon in hairy cell leukaemia: clinical and molecular aspects
Giovanni M Assanto, Costantino Riemma, Francesco Malaspina, et al.
BMC Infectious Diseases
|
September 20, 2014
microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus
Roberto Bruni, Cinzia Marcantonio, Alessandro Pulsoni, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 25, 2021
Brentuximab Vedotin and Bendamustine Produce Long-Term Clinical Benefit in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter Real-Life Experience
Marina Moretti, Anna Marina Liberati, Luigi Rigacci, et al.
Chemotherapy
|
December 22, 2022
Impact of Pretransplant Salvage Therapies on Outcome of Hodgkin Lymphoma Patients Performing Allogeneic Transplant
Fulvia Fanelli, Stefan Hohaus, Maria Cantonetti, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 109) with videos related to
Sort By:
Page
of 11
Leukemia & Lymphoma
|
September 18, 2015
A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma
Stefano Luminari, Maria Goldaniga, Marina Cesaretti, et al.
Cancers
|
July 2, 2021
High Basal Maximal Standardized Uptake Value (SUV<sub>max</sub>) in Follicular Lymphoma Identifies Patients with a Low Risk of Long-Term Relapse
Giovanni Manfredi Assanto, Giulia Ciotti, Mattia Brescini, et al.
Leukemia & Lymphoma
|
October 29, 2009
Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma
Elena Cavalieri, Angela Matturro, Giorgia Annechini, et al.
European Journal of Haematology
|
December 21, 2025
Outpatient Versus Inpatient Azacitidine Plus Venetoclax Regimen in Elderly Acute Myeloid Leukemia: A Multicenter Retrospective Analysis
Deborah Kasmi, Maria Laura Bisegna, Ida Carmosino, et al.
Cancer Medicine
|
March 19, 2016
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years
Beatrice Casadei, Cinzia Pellegrini, Alessandro Pulsoni, et al.
Hematological Oncology
|
December 15, 2022
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study
Giovanni Manfredi Assanto, Alice Di Rocco, Francesco Malfona, et al.
British Journal of Haematology
|
May 1, 2021
The current role of interferon in hairy cell leukaemia: clinical and molecular aspects
Giovanni M Assanto, Costantino Riemma, Francesco Malaspina, et al.
BMC Infectious Diseases
|
September 20, 2014
microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus
Roberto Bruni, Cinzia Marcantonio, Alessandro Pulsoni, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 25, 2021
Brentuximab Vedotin and Bendamustine Produce Long-Term Clinical Benefit in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter Real-Life Experience
Marina Moretti, Anna Marina Liberati, Luigi Rigacci, et al.
Chemotherapy
|
December 22, 2022
Impact of Pretransplant Salvage Therapies on Outcome of Hodgkin Lymphoma Patients Performing Allogeneic Transplant
Fulvia Fanelli, Stefan Hohaus, Maria Cantonetti, et al.
Page
of 11